Ensurge Micropower (ENSU) Q1 2025 earnings summary

Executive summary

• Transitioned from intensive R&D to commercialization after six years and $400 million in equity-funded investment, with no public funding, and achieved key technology milestones including demonstration and shipment of 11-layer/10μm batteries meeting customer expectations.

• Demonstrated and shipped microbattery on 10μm substrate in 2024, confirming fast charging and C-pulse charge capabilities, with a commercial pipeline exceeding 120 potential customers, especially in medtech, wearables, and IoT.

• Strategic focus on joint development agreements and licensing to accelerate commercialization and fund technology development, rather than high-volume in-house production.

• Transitioned to 24/7 manufacturing shifts, implemented roll-to-roll (R2R) production, and filed critical IP for process innovation.

• Entered a critical inflection point, focusing on scalability, strategic partnerships, and commercialization in medtech, IoT, and wearables.

Financial highlights

• Over $350 million invested in technology and IP development over 15 years, with a strong balance sheet post-private placement improving negotiation leverage.

• Reported zero revenue in Q1 2025, down from USD 20 thousand in Q1 2024; operating costs decreased to USD 1,441 thousand (Q1 2025) from USD 3,278 thousand (Q1 2024), mainly due to capitalization of R&D costs.

• Net loss narrowed to USD 1,907 thousand (USD 0.005 per share) from USD 3,759 thousand (USD 0.007 per share) year-over-year.

• Cash balance at March 31, 2025 was USD 3,087 thousand, including USD 1,600 thousand restricted cash; non-current assets increased to USD 8,688 thousand.

• Current financing is sufficient through Q3 2025; traditional loans not pursued due to balance sheet strength, but material uncertainty exists regarding going concern beyond Q3 2025.

Outlook and guidance

• Targeting delivery of 150,000 batteries to a lead customer in the second half of the year, with plans to ramp up manufacturing capacity and deliver on a 150,000 unit contract by end of 2025.

• Commercial production of 28-layer batteries expected to begin after customer validation, with certification processes running in parallel and summer 2024 targeted for 28-layer readiness.

• Time to market for 43-layer batteries will be shorter than for 28-layer, and company plans to expand deposition and laser processing, execute targeted licensing agreements, and pursue new JDAs.

• Focus on scaling manufacturing, cost optimization, and leveraging the San Jose battery incubation center for co-development.

• Well positioned to capture value through licensing and product commercialization in upcoming quarters.